bioRxivImmunologyPreprint
Robust T and B cell activation is associated with rapid clearance of infectious SARS-CoV-2
Lily ZemelkoiD, Rafael Tiburcio, Yen Y. Wang, Christian M. Constantz, Gina M. Borgo, Wenxuan Chen, Matthew H. SpitzeriD, Khamal A. Anglin, Scott Lu, Sarah A. Goldberg, Michel TassettoiD, Miguel A. Garcia-Knight, Steven G. DeeksiD, Raul AndinoiD, Jeffrey N. MartiniD, Peter W. HuntiD, Michael J. PelusoiD, J. Daniel Kelly, Amelia N. DeitchmaniD, Rachel L. RutishauseriD
Abstract
The immunologic correlates of rapid clearance of SARS-CoV-2 shedding are not well understood, partly due to challenges of collecting samples early after infection and the fact that most studies do not measure infectious virus. Here, we performed mass cytometry profiling of peripheral blood cells collected from people 4-6 days after onset of symptoms from acute SARS-CoV-2 infection who underwent daily nasopharyngeal testing for SARS-CoV-2 culture positivity. We identified broad and coordinated activation of innate and adaptive immune cells in unvaccinated individuals with primary infection. Faster clearance of infectious virus shedding was associated with robust adaptive immune cell activation and proliferation, namely among cytotoxic CD8+, CD4+, and {gamma}{delta} T cells and plasmablasts. In contrast, vaccinated individuals who rapidly cleared breakthrough infection showed minimal cellular immune activation. Our findings identify early immune correlates of rapid clearance of infectious SARS-CoV-2 shedding that may inform future prevention and therapeutic approaches to reduce disease burden and transmission.
- organism: human
- assay: flow cytometry
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rapid recall and de novo T cell responses during SARS-CoV-2 breakthrough infection
M. Koutsakos, A. Reynaldi, … J. A. Juno·bioRxiv·Dec 19, 2022
- Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
N. Le Bert, H. E. Clapham, … C. C. Tam·bioRxiv·Nov 25, 2020
- Early induction of SARS-CoV-2 specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
A. T. Tan, M. Linster, … A. Bertoletti·bioRxiv·Oct 15, 2020
- Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2
S. I. Ramirez, P. G. Lopez, … ACTIV-2/A5401 Study Team·bioRxiv·Oct 25, 2023
- Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2
B. Israelow, T. Mao, … A. Iwasaki·bioRxiv·May 19, 2021
- Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells followed by production of potent neutralizing antibodies
M. M. Painter, T. S. Johnston, … E. J. Wherry·bioRxiv·Feb 5, 2023